Drug intelligence / Profile preview

2-O-hexyldiglycerol

Development stage
Preclinical
Modality
Small Molecules
Administration
Intra-arterial
01

Overview

2-O-hexyldiglycerol is a short-chain alkylglycerol (AG) that acts as a transient and reversible blood-brain barrier (BBB) opening agent. It is primarily utilized as a drug delivery adjuvant to facilitate the penetration of therapeutic compounds, ranging from small molecules like methotrexate to large proteins such as globulins and antibodies, into the brain parenchyma. The mechanism of action involves increasing paracellular permeability by inducing the redistribution of tight junction-associated proteins, including claudin-5 and β-catenin, and potentially modulating the endothelial cytoskeleton. Research indicates that its effects are short-lived and do not permanently disrupt the complexity of tight junction strands, making it a promising tool for overcoming the BBB in the treatment of brain tumors and other central nervous system disorders.

Other names
2-O-hexyl-diglycerol2-hexyl-diglycerol
02

Targets

CTNNB1 (Beta-catenin)CLDN5 (Claudin-5)

Beyond the preview

Go deeper on 2-O-hexyldiglycerol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 2-O-hexyldiglycerol.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call